Comment on CMS-2026-1255-0001

Summary: Natera, a diagnostics company, supports the proposed action to address prior authorization barriers for laboratory tests. They argue that current prior authorization requirements often create unnecessary administrative burdens and patient delays, and they propose specific safeguards such as prohibiting denials based solely on the date of authorization request and requiring the acceptance of test requisition forms as valid documentation.